Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 14  |  Issue : 7  |  Page : 1655--1659

Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance


Xinwen Li1, Xiaojuan Wei2, Huirong Xu3, Zuowei Sha3, Aiqin Gao2, Yuping Sun2, Juan Li2, Liyou Xu4 
1 Department of Oncology, Jinan Central Hospital, Affiliated to Shandong University, Jinan; Department of Infectious Diseases, Zibo Central Hospital, Zibo, Shandong, China
2 Department of Oncology, Jinan Central Hospital, Affiliated to Shandong University, Jinan, Shandong, China
3 Department of Pathology, Zibo Central Hospital, Zibo, Shandong, China
4 Department of Hepatobiliary and Pancreatic Surgery, Jinan Central Hospital, Affiliated to Shandong University, Jinan, Shandong, China

Correspondence Address:
Juan Li
Department of Oncology, Jinan Central Hospital, Affiliated to Shandong University, 105 Jiefang Road, Jinan, Shandong
China
Liyou Xu
Department of Hepatobiliary and Pancreatic Surgery, Jinan Central Hospital, Affiliated to Shandong University, 105 Jiefang Road, Jinan, Shandong
China

Background: Leukocyte immunoglobulin-like receptor B2 (LILRB2) has recently been considered a promising tumor promoter in human cancers. Materials and Methods: In this study, the expression of LILRB2 was assessed in 82 samples of surgically resected human hepatocellular carcinoma (HCC) tissues using immunohistochemistry (IHC). Results: LILRB2 was overexpressed in HCC tissues and its expression was positively and significantly correlated with poor prognostic features of HCC patients, including poor cell differentiation, larger primary tumor size, and shorter overall survival. In addition, there was a positive correlation between the expression of LILRB2 and its classical ligand human leukocyte antigen G in human HCC tissues. Conclusion: LILRB2 might play an important role in HCC progression and correlate with poor prognosis of HCC.


How to cite this article:
Li X, Wei X, Xu H, Sha Z, Gao A, Sun Y, Li J, Xu L. Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance.J Can Res Ther 2018;14:1655-1659


How to cite this URL:
Li X, Wei X, Xu H, Sha Z, Gao A, Sun Y, Li J, Xu L. Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance. J Can Res Ther [serial online] 2018 [cited 2022 Oct 5 ];14:1655-1659
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2018;volume=14;issue=7;spage=1655;epage=1659;aulast=Li;type=0